Redeye interview with CEO Kristina Torfgård
Date: 2021-03-01Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund.
In this interview, Kristina talks about highlights from Alzinova’s year-end report 2020, the upcoming clinical study with therapeutic vaccine, ALZ-101 and summarizes her first year as CEO for Alzinova.
Click the image below to watch the video (in Swedish).
